| abstract |
FIELD: chemistry. n SUBSTANCE: invention relates to novel compounds of general formula (I) , compositions, as well as to use of said compounds to prepare medicinal agents for treating pathologies mediated by type I vanilloid receptors (TRPV1). In general formula (I), X represents two hydrogen atoms, a π-bond, an oxygen atom or methylene; R2 represents phenyl, benzyl and phenethyl; R3 represents hydrogen, 2hydroxyethyl or 2-aminoethyl. n EFFECT: wider field of using said compounds. n 4 cl, 2 tbl, 18 ex |